RKLB Stock Price Forecast – Why Raymond James Is Betting Big on Rocket Lab
Rocket Lab USA (RKLB) shares rose 2% pre-market after Raymond James initiated coverage with an Outperform rating and $80 price target, citing growth potential. The company completed its 16th Electron launch in 2026, deploying a satellite. Analyst Brian Gesuale highlights RKLB's vertical integration and expects positive EBITDA by 2027/2028, though notes integration risks from acquisitions.
How this was made
The 30-second read
Why it matters
The analyst coverage adds a fresh valuation perspective, likely spurring short‑term buying.
Market read
New analyst coverage and recent launch activity provide a catalyst for RKLB's price movement.
What to watch
Potential delays in Neutron development and integration challenges with Mynaric may temper growth.
Background
Rocket Lab recently completed its 16th Electron launch of 2026 and announced a $155.3 M acquisition of Mynaric.
Ticker impact
Raymond James initiated coverage with an Outperform rating and $80 price target, driving a 2% pre‑market rise.
Potential further upside toward the $80 target over the next weeks.
New coverage and price target provide a clear catalyst; the stock is already reacting positively.
Market effects
Positive signal for the small‑cap aerospace launch sector, may lift peers.
U.S. aerospace and satellite launch market sees renewed investor interest.
Limited to niche space launch industry, but could affect global launch service competition.
Counterpoint
The price target assumes successful integration of recent acquisitions; execution risk could limit upside.
Key entities
- Analyst FirmRaymond James
Initiated coverage with Outperform rating and $80 price target.
- Acquired CompanyMynaric
German laser communications specialist acquired for $155.3 M.
